[Fournier's gangrene caused by Streptococcus agalactiae in a non-pregnant woman].
Batista
Nínive
N
Fernández
M Paula
MP
Gambra
M Luisa
ML
Rodríguez
Lesbia
L
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003646:Debridement; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D004198:Disease Susceptibility; D004359:Drug Therapy, Combination; D005260:Female; D018934:Fournier Gangrene / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D006801:Humans; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D010502:Perineum; D010878:Piperacillin / Q000008:administration & dosage / Q000627:therapeutic use; D012086:Reoperation; D013290:Streptococcal Infections / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D013292:Streptococcus agalactiae / Q000302:isolation & purification*; D000078142:Tazobactam
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D002981:Clindamycin; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin